AstraZeneca

We're transforming the future of healthcare by unlocking the power of what science can do.

Community Guidelines:

[AstraZeneca @AstraZeneca]

We're proud to be recognised among the top 3 in the 2026 Access to Medicine Index. By 2030, we aim to reach 400 million people from underserved communities with our medicines and Health Equity programmes.

Read more about our results: https://t.co/pruw4DmDZ7

@AtMIndex

#HealthEquity #ATMIndex10 #AccessToMedicine

[AstraZeneca @AstraZeneca]

Our pipeline has delivered 12 key positive Phase III programme readouts year-to-date and 47 approvals in major markets since our Q4 2025 results.

Learn more: https://t.co/l2XUX5F4cO

#AZN #FinancialResults $AZN

[AstraZeneca @AstraZeneca]

For #Investors and #Media only.

Our 9M and Q3 2026 results are now available, highlighting continued strong commercial performance, with Total Revenue up 7%.

Learn more: https://t.co/l2XUX5F4cO

#AZN #FinancialResults $AZN

[AstraZeneca @AstraZeneca]

Core EPS increased 14% in 9M 2026.

Learn more: https://t.co/l2XUX5F4cO

#AZN #FinancialResults $AZN

[AstraZeneca @AstraZeneca]

For #Investors:

We’ll be sharing our 9M and Q3 2026 performance update at 07:00 GMT on 30 October 2026.

An accompanying webcast for investors and analysts will take place at 14:30 GMT. Register to attend virtually here: https://t.co/iCjKUVQkWD

$AZN

[AstraZeneca @AstraZeneca]

🧬Today marks the opening of our new global R&D centre in Cambridge, Massachusetts, US.

Bringing together exceptional talent and cutting-edge technologies to help accelerate scientific discovery and advance the next generation of medicines. Learn more: https://t.co/65zqD3mnv7

$AZN #WhatScienceCanDo

[AstraZeneca @AstraZeneca]

At #ClimateWeekNYC, we shared how partnership is critical for healthier people, health systems and the planet.

Highlights included: our $100m Young Health Programme commitment, a new tool that models the environmental impact of care pathways and the European Network on Climate and Health Education reaching 6,000 medical students.

Thanks to colleagues, partners and young leaders who made this progress possible.

[AstraZeneca @AstraZeneca]

We’re investing more than $100m in our Young Health Programme 2010 to 2030, in partnership with @UNICEF and 60 NGO partners.

By 2030, the programme aims to reach 10m more young people in underserved communities and train 800,000 youth advocates. Learn more: https://t.co/Gs3bRKpzmV

#YoungHealthProgramme

[AstraZeneca @AstraZeneca]

Patient care delivery accounts for around 40% of emissions from the healthcare sector.

Today we're launching CARESA, a free tool that helps health systems estimate the environmental footprint of care pathways and explore opportunities for more sustainable care🌍

🔗https://t.co/G1o4NbdSQX

[AstraZeneca @AstraZeneca]

Named #5 in TIME’s World’s Best Companies and ranked #1 in our industry 🌍

Behind this recognition: 96,000+ colleagues, partners and suppliers working together for people, society and the planet.

https://t.co/26yssO820s

#WhatScienceCanDo #TIME #WorldsBestCompanies

[AstraZeneca @AstraZeneca]

32 young leaders from 24 countries. One shared goal: better health.

Meet our 2026 Young Health Programme Impact Fellows and Scholars taking action on health equity, health systems resilience and climate and nature.

With @OneYoungWorld and @YouthAssembly.

#YoungHealthProgramme

[AstraZeneca @AstraZeneca]

Since our FY 2025 results, our pipeline has delivered 6 key positive Phase III programmes and 8 first approvals in major markets.

Learn more: https://t.co/cwAB1pudWa

#AZN #FinancialResults $AZN

[AstraZeneca @AstraZeneca]

For #Investors and #Media only.

Our H1 2026 results are now available, highlighting strong growth momentum, with Total Revenue up 6% and continued pipeline delivery.

Learn more: https://t.co/cwAB1pudWa

#AZN #FinancialResults $AZN

[AstraZeneca @AstraZeneca]

In H1 2026, Core EPS increased 11% reflecting strong commercial execution and confidence in our long-term outlook.

Learn more: https://t.co/cwAB1pudWa

#AZN #FinancialResults $AZN

[AstraZeneca @AstraZeneca]

Named among @TIME World's Most Sustainable Companies for the third consecutive year.

Sustainability is embedded in our strategy and how we operate — helping us build a more resilient, efficient business as we deliver life-changing medicines and support a healthier future for people and the planet.

Learn more: https://t.co/OfHvdV7GYc

#WhatScienceCanDo

[AstraZeneca @AstraZeneca]

We focus on advancing research and understanding of generalised myasthenia gravis (MG), guided by those affected and aiming to improve care and outcomes.

#MGAwarenessMonth #MyastheniaGravis #RareDiseases

[AstraZeneca @AstraZeneca]

Today we rang the opening bell at @NYSE to mark our recent share listing and harmonised trading across New York, London and Stockholm. This moment reflects the science, innovation and teamwork helping us turn bold ideas into life-changing medicines.

#AZN #WhatScienceCanDo

[AstraZeneca @AstraZeneca]

Named one of @FinancialTimes Europe’s Climate Leaders for the 6th consecutive year.

Our $1bn Ambition Zero Carbon programme has delivered:

↘️88% cut in Scope 1 & 2 emissions

🔋81% EV fleet

💡80%+ supplier spend with SBT partners.

Read more: https://t.co/toabTDOX3r

#WhatScienceCanDo